MetaCap

Edwards Lifesciences Earnings

NYSE: EWHealth CareIndustrial SpecialtiesUSD

83.84-0.40 (-0.47%)

Market open · Delayed 15 min · as of Oct 9, 1:09 PM ET

Next earnings date

Thu, Oct 29, 2026

Fiscal period

Sep/2026

EPS estimate

$0.73

Edwards Lifesciences earnings summary

Edwards Lifesciences is scheduled to report Sep/2026 earnings on Oct 29, 2026, with analysts expecting EPS of $0.73. In its most recent report on Aug 4, 2026 (Q2 2026), EW posted EPS of $0.42. Revenue for the quarter was $1.74 billion.

Quarterly EPS is down 25.0% from the same quarter a year earlier. Across the last 16 reports, EW shares moved an average of 3.6% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.

Summary generated from market data by MetaCap's automated system. Methodology

EW earnings history

Edwards Lifesciences reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 4, 2026—$0.42—+2.1%
May 6, 2026—$0.66—+1.8%
Feb 25, 2026—$0.16—-5.6%
Nov 5, 2025—$0.50—+3.5%
Aug 6, 2025—$0.56—-0.1%
May 6, 2025—$0.61—+5.9%
Feb 28, 2025—$0.65—-1.8%
Nov 6, 2024—$5.13—+2.3%
Jul 31, 2024—$0.61—+6.3%
Apr 29, 2024—$0.58—+1.7%
Oct 27, 2023—$0.63—+8.7%
Jul 28, 2023—$0.50—-5.0%
Apr 28, 2023—$0.56—+0.9%
Feb 13, 2023—$0.65—-2.9%
Oct 28, 2022—$0.55—-3.3%
Jul 29, 2022—$0.65—+5.6%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related